Nothing Special   »   [go: up one dir, main page]

ES2081097T3 - Vacuna contra los nematodos. - Google Patents

Vacuna contra los nematodos.

Info

Publication number
ES2081097T3
ES2081097T3 ES92904571T ES92904571T ES2081097T3 ES 2081097 T3 ES2081097 T3 ES 2081097T3 ES 92904571 T ES92904571 T ES 92904571T ES 92904571 T ES92904571 T ES 92904571T ES 2081097 T3 ES2081097 T3 ES 2081097T3
Authority
ES
Spain
Prior art keywords
vaccine against
against nematodes
nematode
animal
antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES92904571T
Other languages
English (en)
Inventor
Phillip John Sharp
Barry Maxwell Wagland
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Commonwealth Scientific and Industrial Research Organization CSIRO
Biotech Australia Pty Ltd
Original Assignee
Commonwealth Scientific and Industrial Research Organization CSIRO
Biotech Australia Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Commonwealth Scientific and Industrial Research Organization CSIRO, Biotech Australia Pty Ltd filed Critical Commonwealth Scientific and Industrial Research Organization CSIRO
Application granted granted Critical
Publication of ES2081097T3 publication Critical patent/ES2081097T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • A61P33/10Anthelmintics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43536Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms
    • C07K14/4354Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from worms from nematodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

SE PRESENTA UN ANTIGENO SUBSTANCIALMENTE PURIFICADO DERIVADO DE ESPECIES PARASITAS DE NEMATODOS, QUE CUANDO SE ADMINISTRA A UN ANIMAL ES CAPAZ DE PROTEGER AL ANIMAL DE LA INFECCION POR UNA SEGUNDA ESPECIE PARASITA DE NEMATODO, EN DONDE LA PRIMERA Y SEGUNDA ESPECIE DE NEMATODOS PUEDE SER LA MISMA O DIFERENTE, Y EL ANTIGENO TIENE UN PESO MOLECULAR APARENTE DE 40 KD SEGUN SE DETERMINA MEDIANTE CONDICIONES DE REDUCCION BAJO SDS-PAGE.
ES92904571T 1991-02-06 1992-02-06 Vacuna contra los nematodos. Expired - Lifetime ES2081097T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AUPK448791 1991-02-06

Publications (1)

Publication Number Publication Date
ES2081097T3 true ES2081097T3 (es) 1996-02-16

Family

ID=3775211

Family Applications (1)

Application Number Title Priority Date Filing Date
ES92904571T Expired - Lifetime ES2081097T3 (es) 1991-02-06 1992-02-06 Vacuna contra los nematodos.

Country Status (12)

Country Link
US (2) US5871738A (es)
EP (1) EP0529019B1 (es)
JP (1) JPH05507208A (es)
AT (1) ATE128729T1 (es)
AU (1) AU663863B2 (es)
CA (1) CA2079871A1 (es)
DE (1) DE69205243T2 (es)
DK (1) DK0529019T3 (es)
ES (1) ES2081097T3 (es)
GR (1) GR3018529T3 (es)
NZ (1) NZ241544A (es)
WO (1) WO1992013890A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014037592A1 (es) * 2012-09-05 2014-03-13 Universidad Complutense De Madrid Proteína recombinante de haemonchus contortus y su aplicación para la producción de una vacuna frente a la hemoncosis

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5492695A (en) * 1992-05-14 1996-02-20 Colorado State University Research Foundation Vaccinating cats against Dirofilaria immitis with an L4 homogenate
ZA936095B (en) * 1992-08-21 1994-03-14 Univ Melbourne Cytokine applications.
US5891376A (en) * 1993-09-17 1999-04-06 Commonwealth Scientific And Industrial Research Organisation Film process
US5753787A (en) * 1995-04-10 1998-05-19 Yale University Nucleic acids encoding ancylostoma secreted protein
US5952194A (en) * 1996-08-01 1999-09-14 Heska Corporation Flea nucleic acid sequences and uses thereof
US7052837B2 (en) * 2001-03-13 2006-05-30 The Board Of Trustees Of The University Of Arkansas Histoplasma capsulatum catalase sequences and their use in the detection of Histoplamsa capsulatum and histoplasmosis
AUPS021402A0 (en) * 2002-01-30 2002-02-21 Agresearch Limited Novel monoclonal antibody and nematode larval antigens
MY160430A (en) 2008-12-12 2017-03-15 Univ Sains Malaysia Recombinant antigen for detection of toxocariasis

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879213A (en) * 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
AU618546B2 (en) * 1987-07-07 1992-01-02 Biotechnology Australia Proprietary Limited Vaccines against animal parasitic nematodes
NZ225295A (en) * 1987-07-07 1991-07-26 Biotech Australia Pty Ltd Nematode antigen, its production and vaccines containing it
JPH03503054A (ja) * 1988-09-26 1991-07-11 バイオテクノロジー・オーストラリア・プロプライエタリー・リミテッド ワクチン
AU629249B2 (en) * 1988-09-26 1992-10-01 Biotechnology Australia Proprietary Limited Vaccine
GB8906156D0 (en) * 1989-03-17 1989-05-04 Munn Edward A Production and use of anthelmintic agents and protective immunogens

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014037592A1 (es) * 2012-09-05 2014-03-13 Universidad Complutense De Madrid Proteína recombinante de haemonchus contortus y su aplicación para la producción de una vacuna frente a la hemoncosis
ES2453391A1 (es) * 2012-09-05 2014-04-07 Universidad Complutense De Madrid Proteína recombinante de Haemonchus contortus y su aplicación para la producción de una vacuna frente a la hemoncosis.

Also Published As

Publication number Publication date
US5734035A (en) 1998-03-31
DK0529019T3 (da) 1996-03-18
JPH05507208A (ja) 1993-10-21
AU663863B2 (en) 1995-10-26
US5871738A (en) 1999-02-16
DE69205243D1 (de) 1995-11-09
WO1992013890A1 (en) 1992-08-20
DE69205243T2 (de) 1996-06-13
ATE128729T1 (de) 1995-10-15
EP0529019B1 (en) 1995-10-04
EP0529019A4 (en) 1993-07-28
EP0529019A1 (en) 1993-03-03
NZ241544A (en) 1994-04-27
CA2079871A1 (en) 1992-08-07
GR3018529T3 (en) 1996-03-31
AU1236992A (en) 1992-09-07

Similar Documents

Publication Publication Date Title
ES2059491T3 (es) Derivados de indol con anillos condensados.
AR003937A1 (es) Compuesto ciclico que tiene efecto antagonico al receptor de taquiquinina, proceso para producirlo y composicion farmaceutica que lo contiene.
AR003433A1 (es) Agente ectoparasiticida, procedimiento para la produccion de dicho agente uso de un compuesto contra insectos parasitos y garrapatas monofagas y para laproduccion de dicho agente.
ES2126966T3 (es) Proceso para la impregnacion hidrofuga de yeso.
ES2155566T3 (es) Uso de derivados de rifamicina para el tratamiento de enfermedades infecciosas por clamidia.
ES2081097T3 (es) Vacuna contra los nematodos.
NO172094C (no) Insekt- og middbeskyttende middel inneholdende substituerte alfa,omega-aminoalkoholderivater, disses anvendelse i slike midler samt nye alfa,omega-aminoalkoholderivater
ATE96822T1 (de) Benzotriazolgruppenhaltiges diorganopolysiloxan.
ES2182114T3 (es) Derivados azabiciclicos de la carbamoiloxi-multilina para empleo antibacteriano.
ES2056153T3 (es) Expectorante que comprende un derivado hidroxialquilcisteina.
FI882358A (fi) Cykliska antikoagulationspeptider.
FI882359A (fi) Cykliska antikoagulationspeptider. pi path slues6208 s880524 mlues6205 m881102
AU7759087A (en) Anthelmintic agents derived from nematodes
NO891894L (no) Fremgangsmaate for fremstilling av antikoagulerende peptidalkoholer.
ES2081607T3 (es) Vacuna contra nematodos.
DK301689D0 (da) 4,5,7,8-tetrahydro-6h-thiazolooe5,4-daaazepiner samt laegemidler med indhold af saadenne forbindelser
FI922058A (fi) Ny bakteriemotverkande foerening
ATE141106T1 (de) Vakzin gegen nematoden
FR2380272A1 (fr) Derives de la coumarine et d'indane-diode, utilisables comme medicament
KR880009644A (ko) 궤양성 대장질환 치료용 약한 조성물
SE7713968L (sv) Basiskt alkylerade ditiosalicylsyraamider, sett for framstellning derav samt anvendning derav som lekemedel
KR890001977A (ko) 피로글루타미드 유도체
ES2174088T3 (es) Espiroxacinas fotocromicas, composiciones y articulos que contienen estos compuestos.
KR910012257A (ko) 벤즈안트라센 화합물 및 이의 제조방법
MX9306822A (es) Derivados de oxa- y tiadiazol.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 529019

Country of ref document: ES